Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial[S] von Jakulj, L., Vissers, M.N., Groen, A.K., Hutten, B.A., Lutjohann, D., Veltri, E.P., Kastelein, J.J.P.

Volltext

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia von Knopp, R.H., Gitter, H., Truitt, T., Bays, H., Manion, C.V., Lipka, L.J., LeBeaut, A.P., Suresh, R., Yang, B., Veltri, E.P.

Volltext

Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia von Ballantyne, C.M., Lipka, L.J., Sager, P.T., Strony, J., Alizadeh, J., Suresh, R., Veltri, E.P.

Volltext

Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia: Long-Term Coadministration of Ezeti... von Ballantyne, C.M., Lipka, L.J., Sager, P.T., Strony, J., Alizadeh, J., Suresh, R., Veltri, E.P.

Volltext

901–41 Preliminary Mortality Results from the Survival with Oral D-Sotalol (SWORD) Trial von Waldo, A.L., Camm, A.J., de Ruyter, H., Friedman, P.L., MacNeil, D.J., Pitt, B., Pratt, C.M., Schwartz, P.J., Veltri, E.P.

Volltext

Ezetimibe reduces low-density lipoprotein cholesterol: results of a phase III, randomized, double-blind, placebo-controlled trial von Knopp, R.H., Gitter, H., Truitt, T., Lipka, L.J., LeBeaut, A.P., Suresh, R., Veltri, E.P.

Volltext

Effect of ezetimibe on serum concentrations of lipid-soluble vitamins von Knopp, R.H., Bays, H., Manion, C.V., Lipka, L.J., Melani, L., LeBeaut, A.P., Suresh, R., Veltri, E.P.

Volltext

Ezetimibe does not decrease the response to cosyntropin stimulation von Bays, H., Knopp, R.H., Mardon, C.V., Lipka, L.J., LeBeaut, A.P., Suresh, R., Veltri, E.P.

Volltext

Pharmacodynamic interaction between fluvastatin and ezetimibe has favorable clinical implications von Kosoglou, T., Meyer, I., Musiol, B., Anderson, L., Reyderman, L., Statkevich, P., Cutler, D.L., Veltri, E.P., Affrime, M.B.

Volltext

Pharmacodynamic interaction between fenofibrate and the cholesterol absorption inhibitor ezetimibe von Kosoglou, T., Guillaume, M., Sun, S., Pember, L.J.C., Reyderman, L., Statkevich, P., Cutler, D.L., Veltri, E.P., Affrime, M.B.

Volltext

Coadministration of ezetimibe and fenofibrate leads to favorable effects on Apo CIII and LDL subfractions von Kosoglou, T., Fruchart, J.-C., Guillaume, M., Pember, L.J.C., Sun, S., Picard, G., Affrime, M.B., Veltri, E.P.

Volltext